Der er fremsat hypoteser om en forbindelse mellem visceral lipomatose og proteasehæmmere (PI) samt lipoatrofi og nukleosid revers transkriptasehæmmere (NRTI).
A connection between visceral lipomatosis and protease inhibitors (PIs), and lipoatrophy and nucleoside reverse transcriptase inhibitors (NRTIs), has been hypothesised.